{"meta":{"query_hash":"c9d81423519b","filters":{"venue":"Pharmaceutical biotechnology"},"cohort_total":7,"direct_labels_cover":0,"predictions_cover":7,"exported":7,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/c9d81423519b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Pharmaceutical+biotechnology"},"results":[{"id":"W1501769303","doi":"10.1007/0-306-46812-3_12","title":"Nucleoside Transporters of Mammalian Cells","year":2002,"lang":"en","type":"review","venue":"Pharmaceutical biotechnology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nucleoside transporter; Nucleoside; Transporter; Biology; Biochemistry; Recombinant DNA; Gene","score_opus":0.055047562898913535,"score_gpt":0.34133976436447827,"score_spread":0.2862922014655647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1501769303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012675404,0.99827254,0.00038331072,0.00014924159,0.00022448103,0.00035357938,0.000104029175,0.000048201062,0.0003378592],"genre_scores_gemma":[0.0012244553,0.99744517,0.0004787365,0.0001233751,0.00020153077,0.0000287253,0.00013073171,0.00007174574,0.00029551506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804074,0.00008358887,0.0006943293,0.0006002912,0.00013005534,0.0004509763],"domain_scores_gemma":[0.9990701,0.000025529964,0.00020743338,0.0005417082,0.000030546198,0.0001246904],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00012400732,0.0004354953,0.0010626952,0.00019231037,0.00003674719,0.0000062739896,0.00060582696,0.0014617911,0.00031598884],"category_scores_gemma":[0.000022836313,0.00038467196,0.0005491669,0.00026998293,0.0003573083,0.0000017627775,0.00014012611,0.0005616738,0.000085408334],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021298552,0.00015823879,0.0000012696015,0.0049270177,0.0003660214,0.00006491832,0.000006084049,0.0000030730362,0.021195397,0.00034595403,0.007820808,0.9650899],"study_design_scores_gemma":[0.00023372858,0.00013237896,8.3198096e-8,0.00042861016,0.0005678238,0.00008313896,0.0000040705354,0.000007972321,0.07895135,0.0000085670445,0.9192391,0.00034317523],"about_ca_topic_score_codex":0.000006529194,"about_ca_topic_score_gemma":6.1793486e-7,"teacher_disagreement_score":0.9647468,"about_ca_system_score_codex":0.000016164395,"about_ca_system_score_gemma":0.000059936632,"threshold_uncertainty_score":0.9998605},"labels":[],"label_agreement":null},{"id":"W2938553686","doi":"10.1007/978-3-030-00710-2_13","title":"An Evidence-Based Practice Approach to Evaluating Biotechnologically Derived Medications","year":2019,"lang":"en","type":"book-chapter","venue":"Pharmaceutical biotechnology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Credence; Clinical Practice; Personalized medicine; Intensive care medicine; Medicine; Precision medicine; Pharmacology; Computer science; Bioinformatics; Biology; Family medicine; Pathology","score_opus":0.5643850137807436,"score_gpt":0.5199422110498995,"score_spread":0.04444280273084411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938553686","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008835196,0.014977889,0.18830055,0.5941332,0.0013734357,0.0069271186,0.0007624601,0.0019093633,0.19073246],"genre_scores_gemma":[0.11077408,0.007400947,0.53755456,0.30837077,0.0018327304,0.0017178964,0.0008172562,0.00081040926,0.030721357],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906059,0.00044266786,0.005159087,0.0023913758,0.00040034205,0.0010006317],"domain_scores_gemma":[0.9897205,0.003706642,0.0032587433,0.0023850536,0.00031424893,0.0006147697],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.018643033,0.000743656,0.0021330484,0.0015690667,0.00031429747,0.00013077233,0.0019437067,0.0032215659,0.0015335853],"category_scores_gemma":[0.020568969,0.0008960775,0.00028619968,0.0003526727,0.0006498653,0.0006008031,0.00036675832,0.0023410367,0.015466281],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008705644,0.00028718324,0.00003717753,0.0003861954,0.00025167046,0.000004484152,0.00008839966,0.00034783073,0.0007953873,0.98945266,0.0033863906,0.0048755845],"study_design_scores_gemma":[0.0013977573,0.0012230818,0.000057915346,0.00066326413,0.00026388522,0.00005755349,0.00027286244,0.05721764,0.00089137914,0.043720346,0.89233965,0.0018946801],"about_ca_topic_score_codex":0.00007383507,"about_ca_topic_score_gemma":0.000008010595,"teacher_disagreement_score":0.9457323,"about_ca_system_score_codex":0.001255762,"about_ca_system_score_gemma":0.000805186,"threshold_uncertainty_score":0.9999606},"labels":[],"label_agreement":null},{"id":"W4242379003","doi":"10.3109/9781420044386-27","title":"Economic Considerations in Medical Biotechnology","year":2013,"lang":"en","type":"book-chapter","venue":"Pharmaceutical biotechnology","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biotechnology; Biology","score_opus":0.03299503653720434,"score_gpt":0.3229753358981535,"score_spread":0.28998029936094916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242379003","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010775129,0.006964171,0.0001547389,0.67555666,0.0009656953,0.0013032571,0.0000401053,0.0015531738,0.3123847],"genre_scores_gemma":[0.37952748,0.2180923,0.0061524543,0.049883183,0.0012243586,0.00046323225,0.00042491397,0.00078122446,0.34345084],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660313,0.000031188716,0.0011267519,0.0011179874,0.0002832413,0.00083769957],"domain_scores_gemma":[0.99813855,0.00025505899,0.00021135832,0.0009969024,0.000049702197,0.0003484069],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0003004178,0.00067000353,0.0013561341,0.0015895376,0.0001067651,0.000014476695,0.00043825363,0.049100056,0.036117285],"category_scores_gemma":[0.00034434354,0.0006183904,0.0002749066,0.00011785226,0.002985504,0.00005167095,0.0005052405,0.018603329,0.0091197],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051276085,0.00011158705,0.000019293933,0.000072541494,0.0003447166,0.0017315145,0.000006349515,7.5091003e-7,0.0018641044,0.950678,0.011342035,0.03377781],"study_design_scores_gemma":[0.0025077737,0.00034539448,0.0000286115,0.0003532325,0.00030697236,0.005114379,0.000010507311,0.0007026524,0.030455234,0.056830287,0.90266186,0.0006830778],"about_ca_topic_score_codex":0.000026586853,"about_ca_topic_score_gemma":0.000075262025,"teacher_disagreement_score":0.8938477,"about_ca_system_score_codex":0.00035678252,"about_ca_system_score_gemma":0.00051876844,"threshold_uncertainty_score":0.9997278},"labels":[],"label_agreement":null},{"id":"W4391317512","doi":"10.1007/978-3-031-30023-3_9","title":"Genomics, Other “OMIC” Technologies, Precision Medicine, and Additional Biotechnology-Related Techniques","year":2024,"lang":"en","type":"book-chapter","venue":"Pharmaceutical biotechnology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biotechnology; Precision medicine; Computational biology; Genomics; Biology; Data science; Engineering; Computer science; Genetics; Genome; Gene","score_opus":0.019641726709367053,"score_gpt":0.3262943696754064,"score_spread":0.3066526429660394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391317512","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016463377,0.35863456,0.015007449,0.13333713,0.003874343,0.0059175645,0.01010128,0.013426145,0.4580552],"genre_scores_gemma":[0.049222823,0.3269145,0.028672438,0.0046969242,0.0031568725,0.00090568454,0.007480703,0.002225908,0.5767242],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972272,0.000012594483,0.00067166996,0.0013352715,0.00020132039,0.0005519815],"domain_scores_gemma":[0.99876,0.000067589,0.0001535946,0.00084194535,0.00006401547,0.000112886635],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022629667,0.00072970183,0.00061947457,0.0007562335,0.0000948326,0.000024093937,0.0006391404,0.0047874902,0.0012198032],"category_scores_gemma":[0.00018760304,0.00067405077,0.00017065505,0.000130144,0.0019213189,0.0000042699876,0.0010689227,0.0016656207,0.0002016601],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078606,0.000034572484,0.000002242477,0.0001723906,0.00056979695,0.00006696199,0.000010623826,0.0000027589192,0.49564856,0.22472407,0.07926152,0.1994279],"study_design_scores_gemma":[0.00023445321,0.00026822687,4.897332e-7,0.00019215596,0.00012946613,0.00027768212,0.000014348355,0.00009935684,0.28611094,0.029947372,0.6822496,0.00047594297],"about_ca_topic_score_codex":0.0000036879173,"about_ca_topic_score_gemma":0.0000073832825,"teacher_disagreement_score":0.60298806,"about_ca_system_score_codex":0.00007888817,"about_ca_system_score_gemma":0.000067067966,"threshold_uncertainty_score":0.9996932},"labels":[],"label_agreement":null},{"id":"W4391317527","doi":"10.1007/978-3-031-30023-3_12","title":"An Evidence-Based Practice Approach to Evaluating Biotechnologically Derived Medications","year":2024,"lang":"en","type":"book-chapter","venue":"Pharmaceutical biotechnology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Computer science","score_opus":0.567950866418649,"score_gpt":0.5287571102412415,"score_spread":0.0391937561774075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391317527","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035469665,0.029358158,0.09846507,0.6656616,0.0013629881,0.004343795,0.0007757222,0.0025041585,0.19717386],"genre_scores_gemma":[0.107994296,0.011785983,0.53669065,0.28021422,0.0031746523,0.003449928,0.0008701328,0.0011381027,0.05468204],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907258,0.00028993213,0.005152196,0.002496475,0.0003826899,0.00095288455],"domain_scores_gemma":[0.9920393,0.0029713002,0.0021145097,0.0019586303,0.00025447796,0.0006617609],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.018087797,0.00074874406,0.0018825007,0.0018568068,0.0003169048,0.00019356715,0.0017130882,0.003024423,0.0012843693],"category_scores_gemma":[0.015984302,0.0008790717,0.00030550442,0.00045203636,0.00074267195,0.00050924526,0.00040547107,0.0026910587,0.016857166],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051853785,0.00020048663,0.0000070246774,0.00048946484,0.0002841348,0.000010748194,0.000101217396,0.00017584329,0.0005542345,0.9903809,0.0038452796,0.0038988031],"study_design_scores_gemma":[0.00058003556,0.0007118512,0.00001027829,0.0007366207,0.0002937885,0.00006301743,0.00022508546,0.050838787,0.0006076736,0.1428224,0.8018091,0.0013014107],"about_ca_topic_score_codex":0.0000729458,"about_ca_topic_score_gemma":0.000009504957,"teacher_disagreement_score":0.8475585,"about_ca_system_score_codex":0.0013305957,"about_ca_system_score_gemma":0.0005334952,"threshold_uncertainty_score":0.9996286},"labels":[],"label_agreement":null},{"id":"W49164610","doi":"10.1007/978-1-4614-6486-0_8","title":"Genomics, Other “Omic” Technologies, Personalized Medicine, and Additional Biotechnology-Related Techniques","year":2013,"lang":"en","type":"book-chapter","venue":"Pharmaceutical biotechnology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biotechnology; Drug development; Drug discovery; Personalized medicine; Computational biology; Pharmaceutical sciences; Function (biology); Emerging technologies; Biology; Drug; Bioinformatics; Computer science; Pharmacology; Genetics","score_opus":0.02125360957323118,"score_gpt":0.3125208855531937,"score_spread":0.2912672759799625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W49164610","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037545913,0.26116288,0.02343889,0.18329553,0.0026804118,0.009589316,0.009515998,0.013434663,0.4931277],"genre_scores_gemma":[0.037387814,0.27794018,0.05354809,0.010267744,0.0027689312,0.0016392196,0.009044124,0.0021610218,0.6052429],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972449,0.000020681187,0.000658851,0.001229926,0.0002003676,0.00064529426],"domain_scores_gemma":[0.9986401,0.000062697574,0.00023117817,0.0008335341,0.00009249564,0.00013999017],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018304739,0.0007826348,0.00072883477,0.0005822814,0.00012373275,0.000020673653,0.00068101124,0.004760146,0.0047575384],"category_scores_gemma":[0.00021457228,0.0007432463,0.00017765377,0.00009913263,0.0031786964,0.000005455416,0.00075126474,0.001436045,0.00022137698],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007063287,0.000042663476,0.0000046832183,0.00010992158,0.00062078953,0.000029806313,0.000013261887,0.0000010861788,0.54850525,0.19863789,0.11499291,0.13697112],"study_design_scores_gemma":[0.0005223718,0.00025776261,0.0000012022077,0.00009673593,0.00011275716,0.0002605545,0.000027225882,0.00007200275,0.22739886,0.009411436,0.76123464,0.00060445035],"about_ca_topic_score_codex":0.000008422815,"about_ca_topic_score_gemma":0.0000052263713,"teacher_disagreement_score":0.6462417,"about_ca_system_score_codex":0.00007496047,"about_ca_system_score_gemma":0.00007744559,"threshold_uncertainty_score":0.9995341},"labels":[],"label_agreement":null},{"id":"W54070097","doi":"10.1007/0-306-47452-2_4","title":"Stability, Characterization, Formulation, and Delivery System Development for Transforming Growth Factor-Beta1","year":2002,"lang":"en","type":"review","venue":"Pharmaceutical biotechnology","topic":"Bone Tissue Engineering Materials","field":"Engineering","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Transforming growth factor; In vivo; Growth factor; Delivery system; In vitro; Cell biology; Biology; Pharmacology; Biotechnology; Receptor; Biochemistry","score_opus":0.07388939125644998,"score_gpt":0.29464380390407546,"score_spread":0.22075441264762546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W54070097","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009671464,0.9357835,0.0577047,0.00004096679,0.00074431824,0.0021994011,0.0003319726,0.0022035697,0.000024421852],"genre_scores_gemma":[0.012082911,0.98482496,0.0020654849,0.0000053937815,0.00011101052,0.00049323624,0.00024409589,0.00016321694,0.000009692268],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978879,0.00003327394,0.0009613288,0.00044238401,0.00012908908,0.0005460359],"domain_scores_gemma":[0.99933815,0.00014169393,0.000091361355,0.00024263244,0.00005488861,0.00013127623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019112571,0.00057273376,0.0013448208,0.0003310361,0.00009396386,0.000051295723,0.000263872,0.0009854265,0.00005422343],"category_scores_gemma":[0.000035374433,0.00055417034,0.00012936983,0.00026094305,0.000060181545,0.00013585895,0.00007059771,0.00040077802,0.000043459928],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028763427,0.000015259471,8.534268e-7,0.058891237,0.00021553542,0.0000037200618,0.00006287995,0.00000265071,0.0029181908,0.0024984295,0.00000831275,0.93538004],"study_design_scores_gemma":[0.0002574732,0.000018413211,0.0000021944475,0.0015605965,0.00028767833,0.0000619145,0.0000040448117,0.0026584854,0.023456283,0.0000067504234,0.9710919,0.00059421145],"about_ca_topic_score_codex":5.2780854e-7,"about_ca_topic_score_gemma":4.2522714e-7,"teacher_disagreement_score":0.97108364,"about_ca_system_score_codex":0.00034633966,"about_ca_system_score_gemma":0.000033773424,"threshold_uncertainty_score":0.99969095},"labels":[],"label_agreement":null}]}